M.L. Medical Enterprises Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 29-05-2024
- Paid Up Capital ₹ 1.92 Cr
as on 29-05-2024
- Company Age 35 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4.23 Cr
as on 29-05-2024
About M.L. Medical Enterprises
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.92 Cr.
The company has closed loans amounting to ₹4.23 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mohan Goenka, Surya Agarwal, Pushpa Goenka, and One other member serve as directors at the Company.
- CIN/LLPIN
U85110AS1989PTC003370
- Company No.
003370
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Nov 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Kamrup, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at M.L. Medical Enterprises?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohan Goenka  | Director | 09-Nov-1989 | Current |
| Surya Agarwal | Director | 27-Dec-2014 | Current |
| Pushpa Goenka | Director | 01-Mar-2023 | Current |
| Neelham Agarwal | Whole-Time Director | 09-Sep-2003 | Current |
Financial Performance and Corporate Structure Insights of M.L. Medical Enterprises.
M.L. Medical Enterprises Pvt. Ltd., for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of M.L. Medical Enterprises?
In 2017, M.L. Medical Enterprises had a promoter holding of 88.25% and a public holding of 11.75%. The company had 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 12 Sep 2013 | ₹8.00 M | Satisfied |
Indian Overseas Bank Creation Date: 15 Sep 2010 | ₹4.80 M | Satisfied |
Indian Overseas Bank Creation Date: 10 Oct 2006 | ₹2.95 Cr | Satisfied |
How Many Employees Work at M.L. Medical Enterprises?
M.L. Medical Enterprises has a workforce of 26 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.L. Medical Enterprises, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.L. Medical Enterprises's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
